Variant report
Variant | esv3341209 |
---|---|
Chromosome Location | chr5:93257221-93259769 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:93259705..93262376-chr5:93294800..93297613,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138217996 | chr5:93257225-93257226 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2167763 | chr5:93257240-93257241 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs538481048 | chr5:93257284-93257285 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74485700 | chr5:93257304-93257305 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558378584 | chr5:93257323-93257324 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571281595 | chr5:93257446-93257447 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186081482 | chr5:93257473-93257474 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190166621 | chr5:93257476-93257477 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181783707 | chr5:93257497-93257498 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542514203 | chr5:93257590-93257591 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556081056 | chr5:93257637-93257638 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575931169 | chr5:93257644-93257645 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544833319 | chr5:93257652-93257653 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141711933 | chr5:93257666-93257667 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12515593 | chr5:93257691-93257692 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs540653249 | chr5:93257746-93257747 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186488819 | chr5:93257771-93257772 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553954028 | chr5:93257824-93257825 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540695260 | chr5:93257947-93257948 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561291477 | chr5:93257991-93257992 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191334456 | chr5:93258004-93258005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112401173 | chr5:93258017-93258018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577303188 | chr5:93258107-93258108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549388008 | chr5:93258108-93258109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185369726 | chr5:93258139-93258140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189684423 | chr5:93258140-93258141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183566083 | chr5:93258143-93258144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571776620 | chr5:93258226-93258227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533671301 | chr5:93258241-93258242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189023429 | chr5:93258369-93258370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553780415 | chr5:93258453-93258454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545819142 | chr5:93258465-93258466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75612844 | chr5:93258511-93258512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562763006 | chr5:93258516-93258517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113943856 | chr5:93258549-93258550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575967919 | chr5:93258603-93258604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544871971 | chr5:93258625-93258626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192971857 | chr5:93258685-93258686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572159777 | chr5:93258713-93258714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531610801 | chr5:93258869-93258870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540380906 | chr5:93259005-93259006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562751502 | chr5:93259011-93259012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183580973 | chr5:93259019-93259020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188274242 | chr5:93259040-93259041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531408201 | chr5:93259073-93259074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541683378 | chr5:93259091-93259092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532057304 | chr5:93259152-93259153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561666235 | chr5:93259153-93259154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565339186 | chr5:93259176-93259177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527843959 | chr5:93259211-93259212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:93194200-93307600 | Weak transcription | Left Ventricle | heart |
2 | chr5:93226800-93269600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr5:93228000-93266600 | Weak transcription | Primary hematopoietic stem cells | blood |
4 | chr5:93249600-93261000 | Weak transcription | NHDF-Ad | bronchial |
5 | chr5:93250000-93262200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr5:93250200-93273800 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
7 | chr5:93250800-93259200 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
8 | chr5:93252200-93284400 | Weak transcription | Primary B cells from peripheral blood | blood |
9 | chr5:93253000-93259000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr5:93253200-93263200 | Weak transcription | Primary T cells fromperipheralblood | blood |
11 | chr5:93255800-93258200 | Enhancers | Fetal Thymus | thymus |
12 | chr5:93256200-93259600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr5:93256400-93258000 | Flanking Active TSS | Dnd41 | blood |
14 | chr5:93256800-93258000 | Enhancers | Thymus | Thymus |
15 | chr5:93257000-93270200 | Weak transcription | Primary T cells from cord blood | blood |
16 | chr5:93257200-93287400 | Weak transcription | Primary B cells from cord blood | blood |
17 | chr5:93257400-93260400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr5:93258000-93258200 | Enhancers | Dnd41 | blood |